Literature DB >> 15020696

Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium.

Joachim R Ehrlich1, Tae-Joon Cha, Liming Zhang, Denis Chartier, Louis Villeneuve, Terence E Hébert, Stanley Nattel.   

Abstract

Cardiomyocytes from the pulmonary vein sleeves (PVs) are known to play an important role in atrial fibrillation. PVs have been shown to exhibit time-dependent hyperpolarization-induced inward currents of uncertain nature. We observed a time-dependent K(+) current upon hyperpolarization of PV and left atrial (LA) cardiomyocytes (I(KH)) and characterized its biophysical and pharmacological properties. The activation time constant was weakly voltage dependent, ranging from 386 +/- 14 to 427 +/- 37 ms between -120 and -90 mV, and the half-activation voltage averaged -93 +/- 4 mV. I(KH) was larger in PV than LA cells (e.g. at -120 mV: -2.8 +/- 0.3 versus-1.9 +/- 0.2 pA pF(-1), respectively, P < 0.01). The reversal potential was approximately -84 mV with 5.4 mm[K(+)](o) and changed by 55.7 +/- 2.4 mV per decade [K(+)](o) change. I(KH) was exquisitely Ba(2+) sensitive, with a 50% inhibitory concentration (IC(50)) of 2.0 +/- 0.3 microm (versus 76.0 +/- 17.9 microm for instantaneous inward-rectifier current, P < 0.01), and showed similar Cs(+) sensitivity to instantaneous current. I(KH) was potently blocked by tertiapin-Q, a selective Kir3-subunit channel blocker (IC(50) 10.0 +/- 2.1 nm), was unaffected by atropine and was significantly increased by isoproterenol (isoprenaline), carbachol and the non-hydrolysable guanosine triphosphate analogue GTPgammaS. I(KH) activation by carbachol required GTP in the pipette and was prevented by pertussis toxin pretreatment. Tertiapin-Q delayed repolarization in atropine-exposed multicellular atrial preparations studied with standard microelectrodes (action potential duration pre- versus post-tertiapin-Q: 190.4 +/- 4.3 versus 234.2 +/- 9.9 ms, PV; 202.6 +/- 2.6 versus 242.7 +/- 6.2 ms, LA; 2 Hz, P < 0.05 each). Seven-day atrial tachypacing significantly increased I(KH) (e.g. at -120 mV in PV: from -2.8 +/- 0.3 to -4.5 +/- 0.5 pA pF(-1), P < 0.01). We conclude that I(KH) is a time-dependent, hyperpolarization-activated K(+) current that likely involves Kir3 subunits and appears to play a significant role in atrial physiology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15020696      PMCID: PMC1665099          DOI: 10.1113/jphysiol.2004.061119

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  38 in total

1.  Tertiapin potently and selectively blocks muscarinic K(+) channels in rabbit cardiac myocytes.

Authors:  H Kitamura; M Yokoyama; H Akita; K Matsushita; Y Kurachi; M Yamada
Journal:  J Pharmacol Exp Ther       Date:  2000-04       Impact factor: 4.030

2.  Potassium channels regulate tone in rat pulmonary veins.

Authors:  E D Michelakis; E K Weir; X Wu; A Nsair; R Waite; K Hashimoto; L Puttagunta; H G Knaus; S L Archer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-06       Impact factor: 5.464

3.  Receptor-mediated hydrolysis of plasma membrane messenger PIP2 leads to K+-current desensitization.

Authors:  E Kobrinsky; T Mirshahi; H Zhang; T Jin; D E Logothetis
Journal:  Nat Cell Biol       Date:  2000-08       Impact factor: 28.824

4.  Molecular basis of downregulation of G-protein-coupled inward rectifying K(+) current (I(K,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic receptor-mediated shortening of action potentials.

Authors:  D Dobrev; E Graf; E Wettwer; H M Himmel; O Hála; C Doerfel; T Christ; S Schüler; U Ravens
Journal:  Circulation       Date:  2001-11-20       Impact factor: 29.690

5.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

Authors:  D Li; S Fareh; T K Leung; S Nattel
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

6.  Synthesis of a stable form of tertiapin: a high-affinity inhibitor for inward-rectifier K+ channels.

Authors:  W Jin; Z Lu
Journal:  Biochemistry       Date:  1999-10-26       Impact factor: 3.162

7.  Pulmonary veins and ligament of Marshall as sources of rapid activations in a canine model of sustained atrial fibrillation.

Authors:  T J Wu; J J Ong; C M Chang; R N Doshi; M Yashima; H L Huang; M C Fishbein; C T Ting; H S Karagueuzian; P S Chen
Journal:  Circulation       Date:  2001-02-27       Impact factor: 29.690

8.  Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation.

Authors:  C Pappone; S Rosanio; G Oreto; M Tocchi; F Gugliotta; G Vicedomini; A Salvati; C Dicandia; P Mazzone; V Santinelli; S Gulletta; S Chierchia
Journal:  Circulation       Date:  2000-11-21       Impact factor: 29.690

9.  Atrial fibrillation in the goat induces changes in monophasic action potential and mRNA expression of ion channels involved in repolarization.

Authors:  L van der Zee; M C Wijffels; C van Leuven; R Dorland; M A Vos; H J Jongsma; M A Allessie
Journal:  J Cardiovasc Electrophysiol       Date:  2000-11

10.  Heterologous facilitation of G protein-activated K(+) channels by beta-adrenergic stimulation via cAMP-dependent protein kinase.

Authors:  C Müllner; D Vorobiov; A K Bera; Y Uezono; D Yakubovich; B Frohnwieser-Steinecker; N Dascal; W Schreibmayer
Journal:  J Gen Physiol       Date:  2000-05       Impact factor: 4.086

View more
  39 in total

1.  Mathematical models of canine right and left atria cardiomyocytes.

Authors:  Ling Xia; Ying-lan Gong; Xiu-wei Zhu; Yu Zhang; Qi Sun; Heng-gui Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2010-06       Impact factor: 3.066

Review 2.  New developments in atrial antiarrhythmic drug therapy.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Nat Rev Cardiol       Date:  2010-03       Impact factor: 32.419

Review 3.  Atrial fibrillation: basic mechanisms, remodeling and triggers.

Authors:  Akiko Shiroshita-Takeshita; Bianca J J M Brundel; Stanley Nattel
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

4.  Effect of input resistance voltage-dependency on DC estimate of membrane capacitance in cardiac myocytes.

Authors:  M Zaniboni; F Cacciani; M Groppi
Journal:  Biophys J       Date:  2005-07-01       Impact factor: 4.033

Review 5.  [New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers].

Authors:  U Ravens; E Wettwer; U Schotten; R Wessel; D Dobrev
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006-06

Review 6.  Novel pharmacological targets for the rhythm control management of atrial fibrillation.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Pharmacol Ther       Date:  2011-08-17       Impact factor: 12.310

7.  Testing Of Box Lesion By Adenosine.

Authors:  Narendra Kumar; Laurent Pison; Taku Meir; Harry Crijns; Jos Maessen
Journal:  J Atr Fibrillation       Date:  2013-12-31

Review 8.  More types than one: multiple muscarinic receptor coupled K+ currents undergo remodelling in an experimental model of atrial fibrillation.

Authors:  A F James; J C Hancox
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

Review 9.  Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.

Authors:  Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-26       Impact factor: 3.000

10.  Cellular bases for human atrial fibrillation.

Authors:  Antony J Workman; Kathleen A Kane; Andrew C Rankin
Journal:  Heart Rhythm       Date:  2008-01-17       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.